Related Experiment Video

Updated: Jul 11, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

PAI-1 as a target in kidney disease

Yufeng Huang1, Nancy A Noble

  • 1Fibrosis Research Laboratory, Division of Nephrology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84108, USA.

Current Drug Targets
|September 28, 2007
PubMed

Insights

New therapies are needed to halt the progression of fibrotic kidney diseases. Targeting Plasminogen Activator Inhibitor-1 (PAI-1) offers a promising approach to combat chronic kidney disease by blocking its fibrogenic effects.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • Fibrotic renal diseases are a significant healthcare burden, with current treatments only slowing, not stopping, progression to renal failure.
  • End-stage renal disease (ESRD) necessitates urgent development of novel therapeutic strategies.
  • Plasminogen Activator Inhibitor-1 (PAI-1) is identified as a key fibrogenic molecule in kidney disease, with functions extending beyond fibrinolysis.

Purpose of the Study:

  • To investigate the role of PAI-1 in the progression of chronic kidney disease.
  • To explore the potential of PAI-1 blockade as a therapeutic strategy for fibrotic renal diseases.

Main Methods:

  • The study focuses on the mechanistic pathways through which PAI-1 contributes to kidney fibrosis.
  • Analysis of PAI-1's effects on extracellular matrix turnover, immune cell infiltration, and growth factor signaling.

Main Results:

  • PAI-1 overexpression contributes to kidney fibrosis by inhibiting matrix turnover.
  • PAI-1 promotes the infiltration of macrophages and myofibroblasts.
  • PAI-1 directly influences transforming growth factor-beta 1 expression, exacerbating kidney damage.

Conclusions:

  • PAI-1 plays a critical role in the pathogenesis of chronic kidney disease.
  • Blocking PAI-1 presents a novel and promising therapeutic avenue to halt or slow the progression of kidney fibrosis.
  • Targeting PAI-1 could help manage the growing epidemic of chronic kidney disease.

More Related Videos

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...